Bio-Techne
TECH
TECH
331 hedge funds and large institutions have $5.42B invested in Bio-Techne in 2018 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 102 increasing their positions, 110 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 296 → 331 (+35)
7% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 110
5.21% less ownership
Funds ownership: 388.76% → 383.55% (-5.2%)
Holders
331
Holding in Top 10
5
Calls
$1.89M
Puts
$1.45M
Top Buyers
| 1 | +$56.7M | |
| 2 | +$26.5M | |
| 3 | +$24.9M | |
| 4 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
+$22.8M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
+$18.3M |
Top Sellers
| 1 | -$103M | |
| 2 | -$52.4M | |
| 3 | -$51.4M | |
| 4 |
Goldman Sachs
New York
|
-$13.7M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$10.8M |